Xu, P., Sun, Y., Fang, Y., Song, Q., Yan, Z., Chen, Y., . . . Zhao, W. (2017). JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide. Nature Portfolio.
Cita Chicago Style (17a ed.)Xu, Peng-Peng, et al. JAM-A Overexpression Is Related to Disease Progression in Diffuse Large B-cell Lymphoma and Downregulated by Lenalidomide. Nature Portfolio, 2017.
Cita MLA (8a ed.)Xu, Peng-Peng, et al. JAM-A Overexpression Is Related to Disease Progression in Diffuse Large B-cell Lymphoma and Downregulated by Lenalidomide. Nature Portfolio, 2017.
Precaución: Estas citas no son 100% exactas.